Stay updated on Immunotherapy in Stage IV Melanoma Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.

Latest updates to the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page
- Check4 days agoChange DetectedLocations section added with state-specific sites (Illinois, Iowa, Kansas, North Carolina, and Tennessee) and page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and several location sections were removed.SummaryDifference0.6%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1; no visible changes to study details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.3.1 added and v3.2.0 removed, and the main study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe government funding status notice/banner at the top of the page has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedTwo screenshots show the same study details page with no core-content changes; only metadata such as update dates appears different.SummaryDifference0.4%

- Check83 days agoChange DetectedThe page now states potential funding-related delays and current NIH Clinical Center operating status, and updates the version to v3.2.0, replacing v3.1.0.SummaryDifference3%

Stay in the know with updates to Immunotherapy in Stage IV Melanoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.